Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.

For your business

Sublingual NMN raises 2PY/4PY catabolites earlier than oral dosing, suggesting faster NAD+ flux—worth considering when timing or route matters clinically.